Background Observations of abnormalities in the diastolic components of intracellular Ca2+ transiPnts in failing human left ventricular myocardium have raised the possibility that reductions in the level or function of sarcoplasmic reticulum proteins involved in Ca2+ transport contribute to the pathophysiology of dilated cardiomyopathy in humans. Functional assays, however, have revealed no differences in ATP-dependent Ca2+ transport or its modulation by phospholamban in sarcoplasmic reticulum-enriched microsomes prepared from nonfailing and failing human left ventricular myocardium. The purpose of the present study was to quantify protein levels of Ca24-transporting ATPase, phospholamban, and calsequestrin directly in nonfailing and failing human left ventricular myocardium.
Background Observations of abnormalities in the diastolic components of intracellular Ca2+ transiPnts in failing human left ventricular myocardium have raised the possibility that reductions in the level or function of sarcoplasmic reticulum proteins involved in Ca2+ transport contribute to the pathophysiology of dilated cardiomyopathy in humans. Functional assays, however, have revealed no differences in ATP-dependent Ca2+ transport or its modulation by phospholamban in sarcoplasmic reticulum-enriched microsomes prepared from nonfailing and failing human left ventricular myocardium. The purpose of the present study was to quantify protein levels of Ca24-transporting ATPase, phospholamban, and calsequestrin directly in nonfailing and failing human left ventricular myocardium. Methods and Results Total protein extracts were prepared from nonfailing left ventricular myocardium from the hearts of unmatched organ donors with normal left ventricular contractility (n=6) and from failing left ventricular myocardium from the excised hearts of transplant recipients with class IV heart failure resulting from idiopathic dilated cardiomyopathy (n=6). Ca2+-transporting ATPase, phospholamban, and calsequestrin contents were determined by quantitative immunoblotting with monoclonal and affinity-purified polyclonal antibodies. The levels of the three proteins were identical in nonfailing and failing human left ventricular myocardium. Equal amounts of protein extract from each sample were subjected to SDS-PAGE, electrophoretic transfer to nitrocellulose membranes, and quantitative immunoblotting with monoclonal and affinity-purified polyclonal antibodies to Ca2'-transporting ATPase, phospholamban, and calsequestrin.10-'2 Bound antibody was quantified by incubating immunoblots with 125I-labeled protein A, excising the appropriate mobility bands, and measuring bound radioactivity (Fig 1) . To ensure the validity of the method of quantitation, aliquots of one sample were applied at amounts that were one half and twice the amounts applied for the other samples (Fig 1, lanes 12  through 14) . Bound radioactivity varied virtually linearly with protein over this range (Fig 2) .
Conclusions
The quantitation of Ca2t-transporting ATPase, phospholamban, and calsequestrin in protein extracts of nonfailing and failing human left ventricular myocardium is represented in Fig 3. There were no differences between nonfailing and failing left ventricular myocardium with respect to the levels of any of these proteins. The results in Fig 3 are derived from Ca2 -transporting ATPase and phospholamban were quantified immunochemically using the same antibodies that were used to quantify these proteins in our experiments. 30 The contents of both proteins were found to be diminished in hypertrophic murine right ventricular myocardium. The discrepancies between these findings in animal models and the lack of change in the protein levels or activity of the Ca2+-transporting ATPase and phospholamban in failing human myocardium suggest that observations made in currently available animal models may be limited in their applicability to dilated cardiomyopathy in humans. The development of animal models of dilated cardiomyopathy that more closely mimic the molecular pathophysiology of the human disease may be helpful in future studies.
In summary, our results indicate that protein levels of Ca2-transporting ATPase, phospholamban, and calsequestrin are not diminished in failing human left ventricular myocardium and that downregulation of the Ca2-transporting ATPase and phospholamban is not part of the molecular pathophysiology of dilated cardiomyopathy in humans.
